← Back to Search

Behavioral Intervention

Treatment for Sexually Transmitted Infections (CH-II Trial)

N/A

Waitlist Available

Led By Susan L Davies

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

African American young adults Aged 18-25 Living in the Birmingham USA Competent to give informed consent

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

CH-II Trial Summary

This trial will test an HIV prevention intervention delivered through entertainment education. It will target African Americans aged 18-25 who live in disadvantaged neighborhoods in Birmingham, Alabama.

Eligible Conditions

Sexually Transmitted Infections
Human Immunodeficiency Virus Infection

CH-II Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

CH-II Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Condom Use Self-Efficacy Scale

HIV Knowledge Questionnaire-18

Perceived HIV-related Stigma

Secondary outcome measures

HIV Testing Questionnaire

Timeline Followback

CH-II Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: TreatmentActive Control2 Interventions

Participants viewed informational video content plus entertainment content

Group II: ControlPlacebo Group1 Intervention

Participants viewed entertainment content only

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,589 Previous Clinical Trials

2,280,020 Total Patients Enrolled

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,477,068 Total Patients Enrolled

Susan L DaviesPrincipal InvestigatorUniversity of Alabama at Birmingham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants being welcomed into this clinical trial?

"Presently, this medical trial is not searching for participants. The original posting date was April 3rd 2015 and the latest edits were made on July 6th 2022. At present there are 514 other clinical trials open to enrolment from patients."

Answered by AI

Could I be a potential participant in this research undertaking?

"To qualify for this medical trial, potential enrollees must have a positive diagnosis of HIV and be between 18 to 25 years old. A total of 334 participants are required."

Answered by AI